Jane Gidudu

4.9k total citations
30 papers, 570 citations indexed

About

Jane Gidudu is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Jane Gidudu has authored 30 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 16 papers in Health and 12 papers in Epidemiology. Recurrent topics in Jane Gidudu's work include Vaccine Coverage and Hesitancy (16 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Influenza Virus Research Studies (7 papers). Jane Gidudu is often cited by papers focused on Vaccine Coverage and Hesitancy (16 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Influenza Virus Research Studies (7 papers). Jane Gidudu collaborates with scholars based in United States, Switzerland and Canada. Jane Gidudu's co-authors include Katrin Kohl, James M. Oleske, Frederick Varricchio, Paul T. Heath, Renald Hennig, Anne Schuind, Scott A. Halperin, Patrick Zuber, Edward Rothstein and Wikke Walop and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Pediatrics.

In The Last Decade

Jane Gidudu

26 papers receiving 545 citations

Peers

Countries citing papers authored by Jane Gidudu

Since Specialization

Citations

This map shows the geographic impact of Jane Gidudu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Gidudu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Gidudu more than expected).

Fields of papers citing papers by Jane Gidudu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Gidudu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Gidudu. The network helps show where Jane Gidudu may publish in the future.

Co-authorship network of co-authors of Jane Gidudu

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Gidudu. A scholar is included among the top collaborators of Jane Gidudu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Gidudu. Jane Gidudu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety of nOPV2 administered during a supplementary immunisation activity in Uganda, 2022: data triangulation from a prospective cohort event monitoring programme and vaccine safety surveillance reports 2025 ·The Lancet Global Health ·Ashley T Longley, Fred Nsubuga, Zunera Gilani, Farrell A. Tobolowsky, Annet Kisakye, Sharon A. Greene, (unknown), (unknown), (unknown), (unknown), (unknown), Brock Stewart, (unknown), Daniel Kyabayinze, Jane Gidudu	0
2	Prioritizing interventions to address healthcare worker barriers to reporting adverse events following immunization in Ghana 2025 ·Vaccine ·(unknown), Erin F. Blau, Alexander Dodoo, (unknown), (unknown), Kwame Amponsa-Achiano, (unknown), (unknown), Jane Gidudu	0
3	Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9–23 months old in Uganda, 2019–2020 — Preliminary report 2024 ·Vaccine ·Rebecca M. Casey, (unknown), (unknown), (unknown), (unknown), (unknown), Courtney N. Sciarratta, Susan Y. Chu, Reena H. Doshi, Andrew Kambugu, Jane Gidudu	0
4	Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data 2024 ·Vaccine ·Sonali Kochhar, David N. Assis, Cara L. Mack, Héctor S. Izurieta, Luigi Muratori, Alma Muñoz, Dale Nordenberg, Jane Gidudu, Erin F. Blau, Simon C. Ling	2
5	Implementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in Nigeria 2023 ·BMJ Global Health ·Talya Shragai, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alash’le Abimiku, (unknown), (unknown), Jane Gidudu, Eugene Lam, Omotayo Bolu	3
6	Progress in Immunization Safety Monitoring — Worldwide, 2020–2022 2023 ·MMWR Morbidity and Mortality Weekly Report ·Erin F. Blau, Madhava Ram Balakrishnan, (unknown), (unknown), (unknown), Shanthi Pal, Jane Gidudu	5
7	Establishing vaccine pregnancy registries and active surveillance studies in low-and middle-income countries: Experience from an observational cohort surveillance project in The Gambia 2023 ·Vaccine ·Sonali Kochhar, Uduak Okomo, (unknown), (unknown), Jane Gidudu, Mustapha Bittaye, (unknown), (unknown), (unknown), Beate Kampmann, Ashley T Longley	1
8	Optimising reporting of adverse events following immunisation by healthcare workers in Ghana: A qualitative study in four regions 2022 ·PLoS ONE ·Raymond Aborigo, Paul Welaga, Abraham Oduro, (unknown), (unknown), Alex Dodoo, (unknown), Jane Gidudu	7
9	Barriers to healthcare workers reporting adverse events following immunization in four regions of Ghana 2019 ·Vaccine ·Jane Gidudu, (unknown), Alex Dodoo, Samuel Bosomprah, George Bonsu, Kwame Amponsa-Achiano, (unknown), (unknown), (unknown), Mawuli Nyaku, (unknown), Abraham Oduro, Raymond Aborigo, Laura Conklin, Paul Welaga, (unknown)	23
10	An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration 2019 ·Vaccine ·Jane Gidudu, (unknown), Katrine Bach Habersaat, Elisabeth Wilhelm, Joseph Woodring, Eric E. Mast, Patrick Zuber, Ananda Amarasinghe, Noele P. Nelson, (unknown), Neetu Abad, Rania A. Tohme	4
11	Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers 2013 ·The Journal of Pediatrics ·S. Williams, Kathryn M. Edwards, Roger Baxter, Philip LaRussa, Neal A. Halsey, Cornelia L. Dekker, Claudia Vellozzi, Colin D. Marchant, Peter D. Donofrio, Tyler Reimschisel, Melvin Berger, Jane Gidudu, Nicola P. Klein	9
12	Active surveillance for influenza vaccine adverse events: The integrated vaccine surveillance system 2011 ·Vaccine ·Gabriella Newes‐Adeyi, Jacey Greece, Sam Bozeman, Deborah Klein Walker, (unknown), Jane Gidudu	14
13	Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? 2010 ·Vaccine ·Michael Gold, Jane Gidudu, Michel Erlewyn‐Lajeunesse, Barbara Law	28
14	Selected Major Issues in Vaccine Safety 2008 ·John K. Iskander, Jane Gidudu, Nelson Arboleda, Wan‐Ting Huang	1
15	Selección de los principales problemas de seguridad de las vacunas 2008 ·John K. Iskander, Jane Gidudu, Nelson Arboleda, Wan‐Ting Huang	0
16	A local reaction at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data 2008 ·Vaccine ·Jane Gidudu, Katrin Kohl, Scott A. Halperin, Sandra Jo Hammer, Paul T. Heath, Renald Hennig, Bernard Hoet, Edward Rothstein, Anne Schuind, Frederick Varricchio, Wikke Walop	70
17	Abscess at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data 2007 ·Vaccine ·Katrin Kohl, L. Ball, Jane Gidudu, Sandra Jo Hammer, Scott A. Halperin, Paul T. Heath, Renald Hennig, Jerry Labadie, Edward Rothstein, Anne Schuind, Frederick Varricchio, Wikke Walop	17
18	Swelling at or near injection site: Case definition and guidelines for collection, analysis and presentation of immunization safety data 2007 ·Vaccine ·Katrin Kohl, Wikke Walop, Jane Gidudu, Leslie D. Ball, Scott A. Halperin, Sandra Jo Hammer, Paul T. Heath, Frederick Varricchio, Edward Rothstein, Anne Schuind, Renald Hennig	26
19	Cellulitis at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data 2007 ·Vaccine ·Scott A. Halperin, Katrin Kohl, Jane Gidudu, L. Ball, Sandra Jo Hammer, Paul T. Heath, Renald Hennig, Jerry Labadie, Edward Rothstein, Anne Schuind, Frederick Varricchio, Wikke Walop	13
20	Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety data 2007 ·Vaccine ·James J. Sejvar, Katrin Kohl, (unknown), Dean A. Blumberg, Therese Cvetkovich, Jochem M. D. Galama, Jane Gidudu, Lakshmi Katikaneni, Najwa Khuri‐Bulos, James M. Oleske, Terhi Tapiainen, Max Wiznitzer	137

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact